Ethambutol/isoniazid/rifampicin
| Combination of | |
|---|---|
| ethambutol | anti-tuberculosis medication |
| isoniazid | anti-tuberculosis medication |
| rifampicin | anti-tuberculosis medication |
| Clinical data | |
| ATC code | |
| Identifiers | |
| ChemSpider |
|
Ethambutol/isoniazid/rifampicin, also known as ethambutol/isoniazid/rifampin, is a medication used to treat tuberculosis.[1] It is a fixed dose combination of ethambutol, isoniazid, and rifampicin.[1] It is used either along or with other antituberculosis medication.[1] It is taken by mouth.[1] Side effects are those of the underlying medications.[1] Use may not be suitable in children.[1]
It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.[2] The wholesale cost in the developing world is about 6.74 to 16.13 USD a month.[3]
See also
References
- ^ a b c d e f World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 142. hdl:10665/44053. ISBN 9789241547659.
- ^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ^ "Rifampicin + Isoniazid + Ethambutol". International Drug Price Indicator Guide. Retrieved 8 December 2016.
 | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |